This MedLibrary.org supplementary page on Arvid Carlsson is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Arvid Carlsson | |
| Born | 25 January 1923 Uppsala, Sweden |
|---|---|
| Nationality | Swedish |
| Alma mater | Lund University |
| Known for | dopamine |
| Notable awards | Nobel Prize in Physiology or Medicine (2000) |
Arvid Carlsson (born January 25, 1923) is a Swedish scientist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. For his work on dopamine, Carlsson won the Nobel Prize in Physiology or Medicine in 2000,[1] along with co-recipients Eric Kandel and Paul Greengard.
Carlsson was born in Uppsala, Sweden, son of Gottfrid Carlsson, historian and later professor of history at the Lund University, where he began his medical education in 1941. In 1944 he was participating in the task of examining prisoners of Nazi concentration camps, who Folke Bernadotte, a member of the royal Swedish family, had managed to bring to Sweden. Although Sweden was neutral during World War II, Carlsson's education was interrupted by several years of service in the Swedish Armed Forces. In 1951, he received his M.L. degree (the equivalent of the American M.D.) and his M.D. (the equivalent of the American Ph.D.). He then became a professor at the University of Lund. In 1959 he became a professor at the Göteborg University.
In 1957 Carlsson demonstrated that dopamine was a neurotransmitter in the brain and not just a precursor for norepinephrine, as had been previously believed.[2][3]
While working at Astra AB, Carlsson and his colleagues were able to derive the first marketed selective serotonin reuptake inhibitor, zimelidine, from brompheniramine.[1]
Carlsson developed a method for measuring the amount of dopamine in brain tissues. He found that dopamine levels in the basal ganglia, a brain area important for movement, were particularly high. He then showed that giving animals the drug reserpine caused a decrease in dopamine levels and a loss of movement control. These effects were similar to the symptoms of Parkinson's disease. By administering to these animals L-Dopa, which is the precursor of dopamine, he could alleviate the symptoms. These findings led other doctors to try using L-Dopa on patients with Parkinson's disease, and found it to alleviate some of the symptoms in the early stages of the disease. L-Dopa is still the basis for most commonly used means of treating Parkinson's disease.[1]
Opposition to fluoridation of drinking water
Carlsson is opposed to the fluoridation of drinking water and, together with 1,700 other health professionals, has signed a petition to end fluoridation of drinking water.[4][5][6]
References
- ^ a b c Barondes, Samuel H. (2003). Better Than Prozac. New York: Oxford University Press, 21-22, 39-40. ISBN 0-19-515130-5.
- ^ Arvid Carlsson, Margit Lindqvist, Tor Magnusson (November 1957). "3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists". Nature 180 (4596): 1200. doi:. PMID 13483658.
- ^ Abbott A (2007). "Neuroscience: the molecular wake-up call". Nature 447 (7143): 368–70. doi:. PMID 17522649. Retrieved on 2008-09-28.
- ^ Over 1,700 Professionals Call for an End to Fluoridation of Drinking Water, Fluoride Action Network
- ^ I-Team: Fluoride Controversy, ABC WJLA/NewsChannel 8, Aug 9, 2007
- ^ Fluoride in drinking water can cause cancer, Svenska Dagbladet (in Swedish)
- Les Prix Nobel. 2001. The Nobel Prizes 2000, Editor Tore Frängsmyr, Nobel Foundation: Stockholm.
External links
|
||||||||
Wikipedia content modification information:
- This page was last modified on 1 October 2008, at 14:14.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Arvid Carlsson".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.